FDA.reportPublic FDA data

← NDC directory

FDA compounder NDC directory

Browse every current FDA compounder source row, including records that do not contain a usable NDC.

Compounder NDC directory#

Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.

Compounder directory page 1 of 1 · 8 matching rows.

Establishment, FEI, Product NDC table
EstablishmentFEIProduct NDCPackage NDCBrandNonproprietary nameActive ingredientsPeriodNormalizationSource date
OLYMPIA PHARMACY01767436873198-01573198-015-03Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; 200 ug/1 mL2026-1valid2026-10-06
OLYMPIA PHARMACY01767436873198-01573198-015-10Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; 200 ug/1 mL2026-1valid2026-10-06
Olympia Pharmacy73198-01573198-015-03RE-1Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 200 mcg/mL30 mg/1 mL; 3 mg/1 mL; 200 ug/1 mL2026-1valid2026-09-18
Olympia Pharmacy73198-01573198-015-10RE-1Papaverine Hydrochloride 30 mg/mL Phentolamine Mesylate 3 mg/mL Alprostadil 200 mcg/mL30 mg/1 mL; 3 mg/1 mL; 200 ug/1 mL2026-1valid2026-09-18
OLYMPIA PHARMACY01767436873198-01573198-015-10Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL2023-1valid2026-10-06
OLYMPIA PHARMACY01767436873198-01573198-015-03Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL2023-1valid2026-10-06
OLYMPIA PHARMACY01767436873198-01573198-015-10Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL2022-2valid2026-10-06
OLYMPIA PHARMACY01767436873198-01573198-015-03Papaverine Hydrochloride; Phentolamine Mesylate; Alprostadil30 mg/1 mL; 3 mg/1 mL; .2 mg/1 mL2022-2valid2026-10-06